Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Collegium Pharmaceutical (NASDAQ: COLL ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Collegium Pharmaceutical re
Torrid Holdings shares jumped 12.83% after hours to $2.52 after the retailer posted second-quarter EPS of $0.05, above the $0.01 estimate, and raised full-year guidance.
Bath & Body Works reported adjusted Q2 earnings of 62 cents per share and raised FY26 GAAP EPS to $3.13–$3.33. Analysts expected 24 cents, with Q2 net sales $1.51 billion.
YETI reported Q2 EPS of $0.67 vs $0.55 consensus and sales of $483.868 million vs $483.890 million consensus, raised FY2026 adjusted EPS guidance to $2.94-$3.00, and cut FY2026 sales guidance to $1.967 billion-$1.985 billion.
Sunrun Inc. (NASDAQ: RUN ) shares are trading lower Thursday morning despite delivering second-quarter 2026 financial results that beat top- and bottom-line estimates. Investor sentiment was weighed down by full-year guidance cuts and a price target reduction by Goldman Sachs from $18 to $15. Sunrun shares are sliding.
DAN reports Q2 sales of $2B